Ultraviolet radiation dosimetry has been performed with the use of a radiochromic film dosimeter called Gafchromic EBT for solar radiation exposure. The film changes from a clear colour to blue colour when exposed to ultraviolet radiation and results have shown that the colour change is reproducible within ±10% at 5 kJ m(-2) UV exposure under various conditions of solar radiation. Parameters tested included changes in season (summer versus winter exposure), time of day, as well as sky conditions such as cloudy skies versus clear skies. As the radiochromic films' permanent colour change occurs in the visible wavelengths the film can be analysed with a desktop scanner with the most sensitive channel for analysis being the red component of the signal. Results showed that an exposure of 5 kJ m(-2) (approximately 1 h exposure in full sun during summer) produced an approximate 0.28 change in the net OD when analysed in reflection mode on the desktop scanner which is significant darkening. The main advantages of this film type, and thus the new EBT2 film which has replaced EBT for measurement of UV exposure, is the visible colour change and thus easy analysis using a desktop scanner, its uniformity in response and its robust physical strength for use in outside exposure situations.
Measurement of solar ultraviolet (UV) radiation is an important aspect of dosimetry for the improved knowledge of UV exposure and its associated health related issues. EBT2 Gafchromic film has been designed by its manufacturers as an improved tool for ionizing radiation dosimetry. The film is stated as exhibiting a significant reduction in UV response. However, results have shown that when exposed to UV from the 'bottom side' i.e. from the thick laminate side, the film exhibits a sensitivity to solar UV radiation which is both measurable and accurate for UV dosimetry. Films were irradiated in this position to known solar UV exposures and results are quantified showing a reproducibility of measurement to within ±7% (1 SD) when compared to calibrated UV meters. With an exposure of 20 J cm(-2) broad spectrum solar UV, the films net OD change was found to be 0.248 OD ± 0.021 OD when analysing the results using the red channel region of an Epson V700 desktop scanner. This was compared to 0.0294 OD ± 0.0053 OD change with exposure to the same UV exposure from the top side. This means that solar UV dosimetry can be performed using EBT2 Gafchromic film utilizing the underside of the film for dosimetry. The main advantages of this film type for measurement of UV exposure is the visible colour change and thus easy analysis using a desktop scanner as well as its uniformity in response and its robust physical strength for use in outside exposure situations.
A simple and reproducible method for increasing desktop scanner uniformity for the analysis of radiochromic films is presented. Scanner uniformity, especially in the non-scan direction, for transmission scanning is well known to be problematic for radiochromic film analysis and normally corrections need to be applied. These corrections are dependant on scanner coordinates and dose level applied which complicates dosimetry procedures. This study has highlighted that using reflectance scanning in combination with a matt, white backing material instead of the conventional gloss scanner finish, substantial increases in the scanner uniformity can be achieved within 90% of the scanning area. Uniformity within ±1% over the scanning area for our epsonV700 scanner tested was found. This is compared to within ±3% for reflection scanning with the gloss backing material and within ±4% for transmission scanning. The matt backing material used was simply 5 layers of standard quality white printing paper (80 g/m(2)). It was found that 5 layers was the optimal result for backing material however most of the improvements were seen with a minimum of 3 layers. Above 5 layers, no extra benefit was seen. This may eliminate the need to perform scanner corrections for position on the desktop scanners for radiochromic film dosimetry.
Total body irradiation (TBI) treatments are used to treat the whole body in preparation for hematopoietic stem cell (or bone marrow) transplantation. Our standard clinical regimen is a 12 Gy in 6 fraction, bi-daily technique using 6 MV X-rays at an extended Source-to-Surface distance (SSD) of 300 cm. Utilizing these characteristics, the beam dose rate is reduced below 7 cGy/min as is standard for TBI treatment. Dose received by the patient is monitored using optically stimulated luminescent dosimetry (OSLD). This work presents some practical calibration corrections based on time-dependant factors for OSLD calibration related to TBI procedure. Results have shown that a negligible difference is seen in OSL sensitivity for 6 MV X-rays irradiated in standard SSD (100 cm) and high dose rate (600 cGy/min) conditions compared to extended SSD (300 cm) and low TBI dose rate (6 cGy/min) conditions. Results have also shown that whilst short term signal fading occurs in the OSL after irradiation at a high dose rate (37% reduction in signal in the first 15 min), thereafter, negligible differences are seen in the OSL signal between 600 and 7 cGy/min irradiations. Thus a direct comparison can be made between calibration OSLs and clinical TBI OSLs between 15 min and 2 h. Finally a table is presented to provide corrections between calibration OSL readout and clinical TBI dose readout for a period up to 7 days. Combining these three results allows users to pre-irradiate their calibration OSLs at standard dose rate and SSD, up to 1 week prior to clinical treatment, and still provide accurate in-vivo dosimetry. This can help with time saving and work efficiency in the clinic.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.